You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 7, April 11, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Disorders
 •Musculoskeletal Syndromes (Chronic Fatigue, Gulf War)
 •Alert me on articles by topic

Management of Aortic Disease in Marfan Syndrome

A Decision Analysis

Seo Young Kim, MD; Neil Martin, BA; Elizabeth C. Hsia, MD, MSCE; Reed E. Pyeritz, MD, PhD; Daniel A. Albert, MD

Arch Intern Med. 2005;165:749-755.

Background  Marfan syndrome is a relatively common heritable disorder of connective tissue that affects numerous organ systems, but the most severe complication is aortic aneurysm and dissection. A variety of medical and surgical approaches are available for managing the cardiovascular complications. Our objective was to compare elective composite graft surgery, elective valve-sparing surgery, and medical management for patients with both Marfan syndrome and thoracic aortic disease on the basis of life expectancy with differing diameters of the aortic root and rate of increase in the aortic root size.

Methods  A Markov decision analysis model was constructed to compare the 2 surgical options with watchful waiting with medical therapy.

Results  For our base-case analysis of a 20-year-old patient with Marfan syndrome and thoracic aortic aneurysm, the aortic valve-sparing option was preferred. It extended life expectancy to 73.8 years compared with the medical treatment option (71.4 years) and with the composite graft surgery (72.7 years). Our results show that there is a better outcome for a patient with an aortic root diameter between 3.0 and 3.5 cm with early prophylactic surgery than with deferred or emergency surgery. Medical treatment was preferred when the aortic root diameter was smaller than 3.0 cm.

Conclusions  Although long-term follow-up data are not yet available, it appears that advances in the technique of valve-sparing surgery have made it the preferred option to composite graft, primarily to avoid the complications of anticoagulation. Our study indicates that patients who have an aortic root diameter of larger than 3.0 cm should be considered for prophylactic aortic surgery.


Author Affiliations: Division of Rheumatology, Department of Medicine (Drs Kim, Hsia, and Albert and Mr Martin), Division of Medical Genetics, Department of Medicine (Dr Pyeritz), Center for Clinical Epidemiology and Biostatistics (Drs Hsia and Albert), Leonard Davis Institute of Health Economics (Dr Albert), University of Pennsylvania, Philadelphia; and Department of Medicine, State University of New York at Buffalo (Dr Kim).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Aortic Diameter >=5.5 cm Is Not a Good Predictor of Type A Aortic Dissection: Observations From the International Registry of Acute Aortic Dissection (IRAD)
Pape et al.
Circulation 2007;116:1120-1127.
ABSTRACT | FULL TEXT  

The time horizons of formal decision analyses
Benbassat and Baumal
QJM 2007;100:383-388.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.